Lipotropin (AOD-9604) is a research peptide that has been studied for its relationship with lipid metabolism and related biological processes. Supplied by PharmaQo for laboratory research, the product is available with documented specifications for researchers to review.
| Feature | Details |
| Brand | Syncom’s |
| Product | Lipotropin – AOD9604 |
| Form | Vial |
| Quantity | 2MG |
| Purity | High Purity |
| Storage | 2–8°C |
| Category | Research Peptide |
| Application | Research Use Only |
Original price was: £54.50.£49.90Current price is: £49.90.
Out of stock
Smart Packaging
Secure Payment
14-Day Returns
Buy Lipotropin AOD-9604 Peptide from Peptide Suppliers UK for laboratory and research requirements. AOD-9604 is an artificially synthesised peptide fragment obtained from the C-terminal portion of human growth hormone (hGH).
Lipotropin is a synthetic 16-amino acid peptide fragment widely used in experiments. It has been investigated in research related to lipid metabolism and lipolytic activity, making it a compound of interest in studies exploring these biological processes.
The main area of study of the AOD-9604 peptide is pre-clinical studies in relation to lipid metabolism and adipose tissue. Researchers have studied its effects on lipolysis, lipogenesis, and metabolism.
AOD-9604 is a chemically altered piece of the C-terminal region of human growth hormone. It was designed to study some of the effects of growth hormone on metabolism without the need to duplicate all of the effects of the hormone.
Synthetic analogue AOD9604 has received special attention in studies of adipose tissue and fat metabolism. Studies have looked at the possibility of the peptide affecting mechanisms of fat degradation and fat storage.
The structure of the peptide is different from that of human growth hormone. Thus, results from studies of growth hormone cannot be automatically applied to AOD-9604.
However, the majority of research on the compound has focused on its effects on lipid metabolism. The first laboratory tests were conducted according to the ability of the substance to induce lipolysis, which is the process of breakdown of stored fat reserves.
Additionally, AOD-9604 has been tested in animals in connection with its possible effect on obesity and body weight control. Certain effects have been observed, but they cannot be regarded as evidence of such processes occurring in humans.
Also, some research has been done in order to investigate the effects that AOD-9604 has on adipose tissue through examining fat metabolic processes and adipocyte development. Human studies have not yet been conducted due to the absence of conclusive results from clinical trials.
AOD-9604 is made from a certain portion of human growth hormone. This peptide comes from the C-terminal end of the human growth hormone and is a smaller synthetic peptide. From its structure, it cannot be regarded as the same as the full human growth hormone.
One area that has been researched for AOD-9604 is lipid metabolism. Researchers have tried to see if AOD-9604 could affect lipolysis and other processes related to lipids.
Researchers have studied AOD-9604 in adipose tissue models to explore its effects on fat deposition and adipocyte biology. Results may differ based on the study model, dosage, and other research conditions.
AOD-9604 is not equivalent to human growth hormone, as it is much larger and has a number of physiological roles.
Researchers are advised to review the available literature before using AOD-9604 in their laboratories.
As per the documentation from the supplier, useful information for analysis may include the following:
Analytical methods used to characterise synthesised peptides include mass spectrometry and chromatography.
Lipotropin AOD-9604 by Syncom is an peptide research compound derived from a sequence of human growth hormone. Peptide formulation, purity, batch, storage, and lab preparation information can be found by consulting existing product literature.
OD-9604 is a peptide research chemical and needs to be used in accordance with the instructions provided by the product manufacturer.
Handling of this substance in general laboratories shall include:
This product is a research chemical and is intended for research purposes only.
No. AOD-9604 is a fragment peptide of human growth hormone that is much smaller than the actual growth hormone.
Yes. Scientists have tested AOD-9604 in laboratories, animals, and even humans. But no results show AOD-9604 as an effective therapy.
The majority of studies have centred around lipid metabolism, lipolysis, adipocyte physiology and metabolic processes.
No. AOD-9604 is a synthetic peptide derived from a part of the human growth hormone. It must be distinguished from naturally occurring human growth hormone.
£41.00
£120.00
£34.00
